215 related articles for article (PubMed ID: 22230570)
1. T cell receptor engineering.
Stone JD; Chervin AS; Aggen DH; Kranz DM
Methods Enzymol; 2012; 503():189-222. PubMed ID: 22230570
[TBL] [Abstract][Full Text] [Related]
2. Display, engineering, and applications of antigen-specific T cell receptors.
Richman SA; Kranz DM
Biomol Eng; 2007 Oct; 24(4):361-73. PubMed ID: 17409021
[TBL] [Abstract][Full Text] [Related]
3. T Cell Receptor Engineering and Analysis Using the Yeast Display Platform.
Smith SN; Harris DT; Kranz DM
Methods Mol Biol; 2015; 1319():95-141. PubMed ID: 26060072
[TBL] [Abstract][Full Text] [Related]
4. High affinity T cell receptors from yeast display libraries block T cell activation by superantigens.
Kieke MC; Sundberg E; Shusta EV; Mariuzza RA; Wittrup KD; Kranz DM
J Mol Biol; 2001 Apr; 307(5):1305-15. PubMed ID: 11292343
[TBL] [Abstract][Full Text] [Related]
5. Structure of a human gammadelta T-cell antigen receptor.
Allison TJ; Winter CC; Fournié JJ; Bonneville M; Garboczi DN
Nature; 2001 Jun; 411(6839):820-4. PubMed ID: 11459064
[TBL] [Abstract][Full Text] [Related]
6. High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3.
Chlewicki LK; Holler PD; Monti BC; Clutter MR; Kranz DM
J Mol Biol; 2005 Feb; 346(1):223-39. PubMed ID: 15663940
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
[TBL] [Abstract][Full Text] [Related]
8. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
9. TCRs with high affinity for foreign pMHC show self-reactivity.
Holler PD; Chlewicki LK; Kranz DM
Nat Immunol; 2003 Jan; 4(1):55-62. PubMed ID: 12469116
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry.
Sami M; Rizkallah PJ; Dunn S; Molloy P; Moysey R; Vuidepot A; Baston E; Todorov P; Li Y; Gao F; Boulter JM; Jakobsen BK
Protein Eng Des Sel; 2007 Aug; 20(8):397-403. PubMed ID: 17644531
[TBL] [Abstract][Full Text] [Related]
11. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
[TBL] [Abstract][Full Text] [Related]
12. Structure of the Vdelta domain of a human gammadelta T-cell antigen receptor.
Li H; Lebedeva MI; Llera AS; Fields BA; Brenner MB; Mariuzza RA
Nature; 1998 Jan; 391(6666):502-6. PubMed ID: 9461220
[TBL] [Abstract][Full Text] [Related]
13. Directed evolution of human T-cell receptors with picomolar affinities by phage display.
Li Y; Moysey R; Molloy PE; Vuidepot AL; Mahon T; Baston E; Dunn S; Liddy N; Jacob J; Jakobsen BK; Boulter JM
Nat Biotechnol; 2005 Mar; 23(3):349-54. PubMed ID: 15723046
[TBL] [Abstract][Full Text] [Related]
14. Engineering higher affinity T cell receptors using a T cell display system.
Chervin AS; Aggen DH; Raseman JM; Kranz DM
J Immunol Methods; 2008 Dec; 339(2):175-84. PubMed ID: 18854190
[TBL] [Abstract][Full Text] [Related]
15. Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.
Neumann F; Sturm C; Hülsmeyer M; Dauth N; Guillaume P; Luescher IF; Pfreundschuh M; Held G
Immunol Lett; 2009 Aug; 125(2):86-92. PubMed ID: 19524620
[TBL] [Abstract][Full Text] [Related]
16. Development of a novel strategy for engineering high-affinity proteins by yeast display.
Richman SA; Healan SJ; Weber KS; Donermeyer DL; Dossett ML; Greenberg PD; Allen PM; Kranz DM
Protein Eng Des Sel; 2006 Jun; 19(6):255-64. PubMed ID: 16549400
[TBL] [Abstract][Full Text] [Related]
17. Directed evolution of soluble single-chain human class II MHC molecules.
Esteban O; Zhao H
J Mol Biol; 2004 Jun; 340(1):81-95. PubMed ID: 15184024
[TBL] [Abstract][Full Text] [Related]
18. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
[TBL] [Abstract][Full Text] [Related]
19. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ
J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353
[TBL] [Abstract][Full Text] [Related]
20. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
